Adsorptive filtration systems for effective removal of blood amyloid β: a potential therapy for Alzheimer’s disease

Nobuya Kitaguchi, Kazunori Kawaguchi, Kazunori Yamazaki, Hiroshi Kawachi, Miwa Sakata, Megumi Kaneko, Masao Kato, Kazuyoshi Sakai, Norimi Ohashi, Midori Hasegawa, Yoshiyuki Hiki, Yukio Yuzawa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Accumulation of amyloid-β protein (Aβ) in the brain causes cognitive impairment in Alzheimer’s disease. We hypothesized that an extracorporeal system that rapidly removed Aβ from the blood may accelerate Aβ drainage from the brain. We previously reported that dialyzers remove blood Aβs effectively, mainly by adsorption on the inner surfaces of the hollow fibers, resulting in lower Aβ accumulation in the brains of patients undergoing hemodialysis than the controls without hemodialysis. The aim of the present study was to create a more convenient and effective blood Aβ removal system using adsorptive filtration, in which the filtrate returned to the body. Filtration from inside to outside of the fibers may enhance the adsorption of plasma Aβs on the surface of micropores inside the hollow fiber walls. Hence, pool solutions of 4 ng/mL synthetic Aβ1–40 and Aβ1–42 peptides (300 mL) or human plasma (1000 mL of 250–346 pg/mL Aβ1–40 and 30–48 pg/mL Aβ1–42) were circulated through polysulfone dialyzers at a flow rate of 50 mL/min to evaluate an adsorptive filtration system. The rates of Aβ reduction from the pool solutions significantly increased along with the filtration rates. A filtration rate of > 1 mL/min, preferably 5–10 mL/min resulted in an 80–100% reduction of Aβs within 30 min of circulation. The rates of Aβs passing through the membrane walls were maintained around 0% for plasma Aβs during circulation. Thus, our adsorptive filtration systems may be useful for removing blood Aβs for patients with Alzheimer’s disease.

Original languageEnglish
Pages (from-to)220-229
Number of pages10
JournalJournal of Artificial Organs
Volume21
Issue number2
DOIs
Publication statusPublished - 01-06-2018

Fingerprint

Amyloid
Alzheimer Disease
Blood
Brain
Adsorption
Renal Dialysis
Fibers
Therapeutics
Artificial Kidneys
Plasma (human)
Plasmas
Serum Amyloid A Protein
Polysulfones
Peptides
Drainage
Flow rate
Membranes

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering
  • Cardiology and Cardiovascular Medicine

Cite this

Kitaguchi, Nobuya ; Kawaguchi, Kazunori ; Yamazaki, Kazunori ; Kawachi, Hiroshi ; Sakata, Miwa ; Kaneko, Megumi ; Kato, Masao ; Sakai, Kazuyoshi ; Ohashi, Norimi ; Hasegawa, Midori ; Hiki, Yoshiyuki ; Yuzawa, Yukio. / Adsorptive filtration systems for effective removal of blood amyloid β : a potential therapy for Alzheimer’s disease. In: Journal of Artificial Organs. 2018 ; Vol. 21, No. 2. pp. 220-229.
@article{e50094f75d0f4fa192d5975a845a5acd,
title = "Adsorptive filtration systems for effective removal of blood amyloid β: a potential therapy for Alzheimer’s disease",
abstract = "Accumulation of amyloid-β protein (Aβ) in the brain causes cognitive impairment in Alzheimer’s disease. We hypothesized that an extracorporeal system that rapidly removed Aβ from the blood may accelerate Aβ drainage from the brain. We previously reported that dialyzers remove blood Aβs effectively, mainly by adsorption on the inner surfaces of the hollow fibers, resulting in lower Aβ accumulation in the brains of patients undergoing hemodialysis than the controls without hemodialysis. The aim of the present study was to create a more convenient and effective blood Aβ removal system using adsorptive filtration, in which the filtrate returned to the body. Filtration from inside to outside of the fibers may enhance the adsorption of plasma Aβs on the surface of micropores inside the hollow fiber walls. Hence, pool solutions of 4 ng/mL synthetic Aβ1–40 and Aβ1–42 peptides (300 mL) or human plasma (1000 mL of 250–346 pg/mL Aβ1–40 and 30–48 pg/mL Aβ1–42) were circulated through polysulfone dialyzers at a flow rate of 50 mL/min to evaluate an adsorptive filtration system. The rates of Aβ reduction from the pool solutions significantly increased along with the filtration rates. A filtration rate of > 1 mL/min, preferably 5–10 mL/min resulted in an 80–100{\%} reduction of Aβs within 30 min of circulation. The rates of Aβs passing through the membrane walls were maintained around 0{\%} for plasma Aβs during circulation. Thus, our adsorptive filtration systems may be useful for removing blood Aβs for patients with Alzheimer’s disease.",
author = "Nobuya Kitaguchi and Kazunori Kawaguchi and Kazunori Yamazaki and Hiroshi Kawachi and Miwa Sakata and Megumi Kaneko and Masao Kato and Kazuyoshi Sakai and Norimi Ohashi and Midori Hasegawa and Yoshiyuki Hiki and Yukio Yuzawa",
year = "2018",
month = "6",
day = "1",
doi = "10.1007/s10047-017-1012-3",
language = "English",
volume = "21",
pages = "220--229",
journal = "Journal of Artificial Organs",
issn = "1434-7229",
publisher = "Springer Japan",
number = "2",

}

Adsorptive filtration systems for effective removal of blood amyloid β : a potential therapy for Alzheimer’s disease. / Kitaguchi, Nobuya; Kawaguchi, Kazunori; Yamazaki, Kazunori; Kawachi, Hiroshi; Sakata, Miwa; Kaneko, Megumi; Kato, Masao; Sakai, Kazuyoshi; Ohashi, Norimi; Hasegawa, Midori; Hiki, Yoshiyuki; Yuzawa, Yukio.

In: Journal of Artificial Organs, Vol. 21, No. 2, 01.06.2018, p. 220-229.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adsorptive filtration systems for effective removal of blood amyloid β

T2 - a potential therapy for Alzheimer’s disease

AU - Kitaguchi, Nobuya

AU - Kawaguchi, Kazunori

AU - Yamazaki, Kazunori

AU - Kawachi, Hiroshi

AU - Sakata, Miwa

AU - Kaneko, Megumi

AU - Kato, Masao

AU - Sakai, Kazuyoshi

AU - Ohashi, Norimi

AU - Hasegawa, Midori

AU - Hiki, Yoshiyuki

AU - Yuzawa, Yukio

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Accumulation of amyloid-β protein (Aβ) in the brain causes cognitive impairment in Alzheimer’s disease. We hypothesized that an extracorporeal system that rapidly removed Aβ from the blood may accelerate Aβ drainage from the brain. We previously reported that dialyzers remove blood Aβs effectively, mainly by adsorption on the inner surfaces of the hollow fibers, resulting in lower Aβ accumulation in the brains of patients undergoing hemodialysis than the controls without hemodialysis. The aim of the present study was to create a more convenient and effective blood Aβ removal system using adsorptive filtration, in which the filtrate returned to the body. Filtration from inside to outside of the fibers may enhance the adsorption of plasma Aβs on the surface of micropores inside the hollow fiber walls. Hence, pool solutions of 4 ng/mL synthetic Aβ1–40 and Aβ1–42 peptides (300 mL) or human plasma (1000 mL of 250–346 pg/mL Aβ1–40 and 30–48 pg/mL Aβ1–42) were circulated through polysulfone dialyzers at a flow rate of 50 mL/min to evaluate an adsorptive filtration system. The rates of Aβ reduction from the pool solutions significantly increased along with the filtration rates. A filtration rate of > 1 mL/min, preferably 5–10 mL/min resulted in an 80–100% reduction of Aβs within 30 min of circulation. The rates of Aβs passing through the membrane walls were maintained around 0% for plasma Aβs during circulation. Thus, our adsorptive filtration systems may be useful for removing blood Aβs for patients with Alzheimer’s disease.

AB - Accumulation of amyloid-β protein (Aβ) in the brain causes cognitive impairment in Alzheimer’s disease. We hypothesized that an extracorporeal system that rapidly removed Aβ from the blood may accelerate Aβ drainage from the brain. We previously reported that dialyzers remove blood Aβs effectively, mainly by adsorption on the inner surfaces of the hollow fibers, resulting in lower Aβ accumulation in the brains of patients undergoing hemodialysis than the controls without hemodialysis. The aim of the present study was to create a more convenient and effective blood Aβ removal system using adsorptive filtration, in which the filtrate returned to the body. Filtration from inside to outside of the fibers may enhance the adsorption of plasma Aβs on the surface of micropores inside the hollow fiber walls. Hence, pool solutions of 4 ng/mL synthetic Aβ1–40 and Aβ1–42 peptides (300 mL) or human plasma (1000 mL of 250–346 pg/mL Aβ1–40 and 30–48 pg/mL Aβ1–42) were circulated through polysulfone dialyzers at a flow rate of 50 mL/min to evaluate an adsorptive filtration system. The rates of Aβ reduction from the pool solutions significantly increased along with the filtration rates. A filtration rate of > 1 mL/min, preferably 5–10 mL/min resulted in an 80–100% reduction of Aβs within 30 min of circulation. The rates of Aβs passing through the membrane walls were maintained around 0% for plasma Aβs during circulation. Thus, our adsorptive filtration systems may be useful for removing blood Aβs for patients with Alzheimer’s disease.

UR - http://www.scopus.com/inward/record.url?scp=85037713897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037713897&partnerID=8YFLogxK

U2 - 10.1007/s10047-017-1012-3

DO - 10.1007/s10047-017-1012-3

M3 - Article

VL - 21

SP - 220

EP - 229

JO - Journal of Artificial Organs

JF - Journal of Artificial Organs

SN - 1434-7229

IS - 2

ER -